November 9, 2023
Applications are being accepted currently for six State Trauma Advisory Council (STAC) positions to be appointed to four-year terms beginning January 2024. Three of the six positions are for surgeons.
November 2, 2023
The MMA joined the AMA and more than 120 other national medical organizations and state medical societies in support of a House of Representative’s proposal to reform the budget-neutrality policies that have been affecting Medicare physician payment levels in recent years.
November 2, 2023
The Task Force on Pregnancy Health and Substance Use Disorders (TFPSUD) met for the first time on October 26 to lay the groundwork for recommending protocols for when physicians, advanced practice registered nurses, and physician assistants should administer a toxicology test and requirements for reporting for prenatal exposure to a controlled substance.
November 2, 2023
The MMA is now offering free intercultural development resources to members and member organizations who have diversity, inclusion, and health equity goals.
October 26, 2023
The MMA will present a virtual forum on “Counseling Against Lethal Means: Why Focusing on the HOW People Attempt Suicide Saves Lives” from noon to 1 pm on Wednesday, November 8.
October 26, 2023
Minnesota physicians have several opportunities to serve on health-oriented state councils or committees.
October 26, 2023
Conversations on Race & Equity (CORE) is a virtual space for physicians to discuss topics that relate to inclusion in healthcare. These conversations are challenging, but necessary to overcome avoidance of these issues, promote understanding, and advance equity. Each session is one hour and includes facilitated dialogue based on curated content.
October 19, 2023
MMA members are encouraged to attend one of two free, hour-long webinars to learn about firearm safety.
October 19, 2023
As part of the Minnesota Health Equity Community of Practice (CoP), Stratis Health will present key findings from its project on health-related social needs assessments and referrals on November 15 from 1 to 2 pm.
October 19, 2023
The U.S. Department of Health and Human Services (HHS) announced on October 13 that HHS and Pfizer have reached an agreement that will transition Paxlovid, the COVID-19 therapeutic, to the commercial market.
